Paul S. Aisen
Affiliations: | Georgetown University Medical Center, Washington, DC, United States |
Area:
Neuroscience Biology, Cognitive Psychology, Psychobiology PsychologyGoogle:
"Paul Aisen"Mean distance: 53433
Children
Sign in to add trainee| Ivy V. Estabrooke | grad student | 2005 | Georgetown University Medical Center |
| Michael S. Rafii | research scientist | 2007-2007 | |
| Robert A Rissman | research scientist | 2008-2008 |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Rissman RA, Langford O, Raman R, et al. (2023) Plasma Aβ42/Aβ40 and phospho-tau217 concentration ratios increase the accuracy of amyloid PET classification in preclinical Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association |
| Touroutoglou A, Katsumi Y, Brickhouse M, et al. (2023) The Sporadic Early-onset Alzheimer's Disease Signature Of Atrophy: Preliminary Findings From The Longitudinal Early-onset Alzheimer's Disease Study (LEADS) Cohort. Alzheimer's & Dementia : the Journal of the Alzheimer's Association |
| Grill JD, Flournoy C, Dhadda S, et al. (2023) Eligibility rates among racially and ethnically diverse US participants in Phase 2 and Phase 3 placebo-controlled, double-blind, randomized trials of lecanemab and elenbecestat in early Alzheimer's disease. Annals of Neurology |
| Nudelman KNH, Jackson T, Rumbaugh M, et al. (2023) Pathogenic variants in the Longitudinal Early-onset Alzheimer's Disease Study cohort. Alzheimer's & Dementia : the Journal of the Alzheimer's Association |
| Veitch DP, Weiner MW, Miller M, et al. (2023) The Alzheimer's Disease Neuroimaging Initiative in the era of Alzheimer's disease treatment: A review of ADNI studies from 2021 to 2022. Alzheimer's & Dementia : the Journal of the Alzheimer's Association |
| Cho H, Mundada NS, Apostolova LG, et al. (2023) Amyloid and tau-PET in early-onset AD: Baseline data from the Longitudinal Early-onset Alzheimer's Disease Study (LEADS). Alzheimer's & Dementia : the Journal of the Alzheimer's Association |
| Nemes S, Logan PE, Manchella MK, et al. (2023) Sex and APOE ε4 carrier effects on atrophy, amyloid PET, and tau PET burden in early-onset Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association |
| Dage JL, Eloyan A, Thangarajah M, et al. (2023) Cerebrospinal fluid biomarkers in the Longitudinal Early-onset Alzheimer's Disease Study. Alzheimer's & Dementia : the Journal of the Alzheimer's Association |
| Eloyan A, Thangarajah M, An N, et al. (2023) White matter hyperintensities are higher among early-onset Alzheimer's disease participants than their cognitively normal and early-onset nonAD peers: Longitudinal Early-onset Alzheimer's Disease Study (LEADS). Alzheimer's & Dementia : the Journal of the Alzheimer's Association |
| Sperling RA, Donohue MC, Raman R, et al. (2023) Trial of Solanezumab in Preclinical Alzheimer's Disease. The New England Journal of Medicine |